Cytokine-conditioned dendritic cells induce humoral tolerance to protein therapy in mice

Human Gene Therapy

Volumn 23, Issue 7, 2012, Pages 769-780

  Sule, Gautam ^a   Suzuki, Masataka ^a   Guse, Kilian ^a   Cela, Racel ^a   Rodgers, John R ^a   Lee, Brendan ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; INTERLEUKIN 10; OVALBUMIN; RECOMBINANT BLOOD CLOTTING FACTOR 8; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; BAGG ALBINO MOUSE; CELL BASED GENE THERAPY; CELL THERAPY; CONTROLLED STUDY; DENDRITIC CELL; HEMOPHILIA A; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KNOCKOUT MOUSE; LONG TERM CARE; MOUSE; NONHUMAN; PHENOTYPE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES; ANTIBODY FORMATION; ANTIGENS; CELLS, CULTURED; DENDRITIC CELLS; FACTOR VIII; IMMUNITY, HUMORAL; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSION; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS; TRANSFORMING GROWTH FACTOR BETA;

MUS;

EID: 84864374178     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2011.225     Document Type: Article

References (47)

1. Abe, M., Harpel, J.G., Metz, C.N., et al. (1994). An assay for transforming growth factor-b using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 216, 276-284. (Pubitemid 24076008)
2. Ahangarani, R.R., Janssens, W., Vanderelst, L., et al. (2009). In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term il-10-dependent antigen-specific unresponsiveness. J. Immunol. 183, 8232-8243.
3. Anderson, B.E., McNiff, J., Yan, J., et al. (2003). Memory CD4+ T cells do not induce graft-versus-host disease. J. Clin. Invest. 112, 101-108. (Pubitemid 38056381)
4. Andre, S., Meslier, Y., Dimitrov, J.D., et al. (2009). A cellular viewpoint of anti-FVIII immune response in hemophilia A. Clin. Rev. Allergy Immunol. 37, 105-113.
5. Barr, D., Tubb, J., Ferguson, D., et al. (1995). Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2, 151-155.
6. Chen, W., Jin, W., Hardegen, N., et al. (2003). Conversion of peripheral CD4+ CD25-naive T cells to CD4+ CD25+ regulatory T cells by TGF-b induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886. (Pubitemid 38032120)
7. Dobrzynski, E., Mingozzi, F., Liu, Y.L., et al. (2004). Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer. Blood 104, 969-977. (Pubitemid 39038015)
8. Ehser, S., Chuang, J.J., Kleist, C., et al. (2008). Suppressive dendritic cells as a tool for controlling allograft rejection in organ transplantation: Promises and difficulties. Hum. Immunol. 69, 165-173.
9. Franchini, M., Mengoli, C., Lippi, G., et al. (2008). Immune tolerance with rituximab in congenital haemophilia with inhibitors: A systematic literature review based on individual patients' analysis. Haemophilia 14, 903-912.
10. Fu, C.L., Chuang, Y.H., Huang, H.Y., and Chiang, B.L. (2008). Induction of IL-10 producing CD4+ T cells with regulatory activities by stimulation with IL-10 gene-modified bone marrow derived dendritic cells. Clin. Exp. Immunol. 153, 258-268.
11. Hayglass, K.T., and Stefura, W. (1991). Antigen-specific modulation of murine IgE and IgG2a responses with glutaraldehydepolymerized allergen is independent of MHC haplotype and Igh allotype. Immunology 73, 24-30.
12. Hoffman, B.E., Martino, A.T., Sack, B.K., et al. (2011). Nonredundant roles of IL-10 and TGF-b in suppression of immune responses to hepatic AAV-factor IX gene transfer. Mol. Ther. 19, 1263-1272.
13. Jonuleit, H., and Schmitt, E. (2003). The regulatory T cell family: Distinct subsets and their interrelations. J. Immunol. 171, 6323-6327. (Pubitemid 37532056)
14. Kulkarni, A.B., Huh, C.G., Becker, D., et al. (1993). Transforming growth factor b1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U.S.A. 90, 770-774. (Pubitemid 23028947)
15. Lacroix-Desmazes, S., Navarrete, A.M., André, S., et al. (2008). Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A. Blood 112, 240-249.
16. Manicassamy, S., and Pulendran, B. (2011). Dendritic cell control of tolerogenic responses. Immunol. Rev. 241, 206-227.
17. Mills, K.H. (2004). Regulatory T cells: Friend or foe in immunity to infection? Nat. Rev. Immunol. 4, 841-855. (Pubitemid 39490760)
18. Moghimi, B., Sack, B.K., Nayak, S., et al. (2011). Induction of tolerance to factor VIII by transient co-administration with rapamycin. J. Thromb. Haemost. 9, 1524-1533.
19. Morelli, A.E., and Thomson, A.W. (2007). Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7, 610-621. (Pubitemid 47123548)
20. Murphy, K.M., Heimberger, A.B., and Loh, D.Y. (1990). Induction by antigen of intrathymic apoptosis of CD4+ CD8+ TCRlo thymocytes in vivo. Science 250, 1720-1723. (Pubitemid 120031881)
21. Nayak, S., Cao, O., Hoffman, B.E., et al. (2009). Prophylactic immune tolerance induced by changing the ratio of antigenspecific effector to regulatory T cells. J. Thromb. Haemost. 7, 1523-1532.
22. Pillemer, B.B., Qi, Z., Melgert, B., et al. (2009). STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells. J. Immunol. 183, 155-163.
23. Qadura, M., Othman, M., Waters, B., et al. (2008). Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cells. J. Thromb. Haemost. 6, 2095-2104.
24. Qian, J., Collins, M., Sharpe, A.H., and Hoyer, L.W. (2000). Prevention and treatment of factor VIII inhibitors in murine hemophilia A. Blood 95, 1324-1329. (Pubitemid 30099842)
25. Ragni, M.V., Wu, W., Liang, X., et al. (2009). Factor VIII-pulsed dendritic cells reduce anti-factor VIII antibody formation in the hemophilia A mouse model. Exp. Hematol. 37, 744-754.
26. Rutella, S., Danese, S., and Leone, G. (2006). Tolerogenic dendritic cells: Cytokine modulation comes of age. Blood 108, 1435-1440. (Pubitemid 44316106)
27. Sato, K., Yamashita, N., and Matsuyama, T. (2002). Human peripheral blood monocyte-derived interleukin-10-induced semi-mature dendritic cells induce anergic CD4+ and CD8+ T cells via presentation of the internalized soluble antigen and cross-presentation of the phagocytosed necrotic cellular fragments. Cell. Immunol. 215, 186-194.
28. Sato, K., Yamashita, N., Baba, M., and Matsuyama, T. (2003a). Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 101, 3581-3589. (Pubitemid 36857945)
29. Sato, K., Yamashita, N., Yamashita, N., et al. (2003b). Regulatory dendritic cells protect mice from murine acute graft-versushost disease and leukemia relapse. Immunity 18, 367-379. (Pubitemid 36351516)
30. Seiler, M.P., Gottschalk, S., Cerullo, V., et al. (2007). Dendritic cell function after gene transfer with adenovirus-calcium phosphate co-precipitates. Mol. Ther. 15, 386-392. (Pubitemid 46111890)
31. Skupsky, J., Zhang, A.H., Su, Y., and Scott, D.W. (2010). B-celldelivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cells. Mol. Ther. 18, 1527-1535.
32. Sprent, J., and Surh, C.D. (2002). T cell memory. Annu. Rev. Immunol. 20, 551-579. (Pubitemid 34293434)
33. SteinbriNK, K., Graulich, E., Kubsch, S., et al. (2002). CD4+ and CD8+ anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 99, 2468-2476. (Pubitemid 34525434)
34. Su, R.J., Epp, A., Feng, J., et al. (2011). Suppression of the immune response to FVIII in hemophilia A mice by transgene modified tolerogenic dendritic cells. Mol. Ther. 19, 1896-1904.
35. Suzuki, M., Cela, R., Bertin, T.K., et al. (2011). NOD2 signaling contributes to the innate immune response against helperdependent adenovirus vectors independently of MyD88 in vivo. Hum. Gene Ther. 22, 1071-1082.
36. Thomson, A.W. (2010). Tolerogenic dendritic cells: All present and correct? Am. J. Transplant. 10, 214-219.
37. Torres-Aguilar, H., Aguilar-Ruiz, S.R., González-Pérez, G., et al. (2010a). Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J. Immunol. 184, 1765-1775.
38. Torres-Aguilar, H., Sanchez-Torres, C., Jara, L.J., et al. (2010b). IL-10/TGF-b-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector/memory T cells from type 1 diabetic individuals. J. Clin. Immunol. 30, 659-668.
39. Tripathy, S.K., Black, H.B., Goldwasser, E., and Leiden, J.M. (1996). Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replicationdefective adenovirus vectors. Nat. Med. 2, 545-550.
40. Wan, Y.Y., and Flavell, R.A. (2006). The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol. Rev. 212, 114-130. (Pubitemid 44116704)
41. Waters, B., and Lillicrap, D. (2009). The molecular mechanisms of immunomodulation and tolerance induction to factor VIII. J. Thromb. Haemost. 7, 1446-1456.
42. Xiao, B.G., Huang, Y.M., and LiNK, H. (2006). Tolerogenic dendritic cells: The ins and outs of outcome. J. Immunother. 29, 465-471. (Pubitemid 44395272)
43. Zahorchak, A.F., Kean, L.S., Tokita, D., et al. (2007). Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques. Transplantation 84, 196-206. (Pubitemid 47205753)
44. Zapata-Gonzalez, F., Rueda, F., Petriz, J., et al. (2007). 9-cis-Retinoic acid (9cRA), a retinoid X receptor (RXR) ligand, exerts immunosuppressive effects on dendritic cells by RXR-dependent activation: Inhibition of peroxisome proliferator-activated receptor c blocks some of the 9cRA activities, and precludes them to mature phenotype development. J. Immunol. 178, 6130-6139. (Pubitemid 46717394)
45. Zhang, A.H., Skupsky, J., and Scott, D.W. (2011). Effect of b-cell depletion using anti-cd20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice. Blood 117, 2223-2226.
46. Zhang, W., Zhang, D., Shen, M., et al. (2010). Combined administration of a mutant TGF-b1/Fc and rapamycin promotes induction of regulatory T cells and islet allograft tolerance. J. Immunol. 185, 4750-4759.
47. Zheng, S.G., Wang, J., and Horwitz, D.A. (2008). Cutting edge: Foxp3+ CD4+ CD25+ regulatory T cells induced by IL-2 and TGF-b are resistant to Th17 conversion by IL-6. J. Immunol. 180, 7112-7116.